Tenderwize
Retour à la recherche

Supply of Medicinal Products

GCS UniHA·LYON, France·EUR 834.6M·Deadline Nov 24, 2031 · 1921 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarderOpen documents
High value
Titre original de l'avis

France – Pharmaceutical products – UniHA_Fourniture de médicaments

80/100

Score d'opportunité

PromisingMedium complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

80 / 100

Complexité

60 / 100

Facteurs de risque

EU funding flag: structured data says EU-funded, XML notice says no EU funds. This may affect contract terms or eligibi...

Award criteria and detailed selection requirements are not provided in the notice.

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Strong opportunity

Faits clés

  • EUR 834.6M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 120 MONTH
  • Supply of medicinal products from identified therapeutic areas (annex 1 of the CCTP).
  • Supply of equivalent medical devices meeting same technical requirements.
Afficher le résumé complet

This is a corrigendum of a Dynamic Purchasing System (SAD) for the supply of pharmaceutical products to member establishments of UniHA in France. The DPS covers various therapeutic areas and lasts 120 months. The estimated total value is €834,612,170. The procedure is restricted, and applications can be submitted until 24 November 2031. Note: There is an inconsistency regarding EU funding (structured data says EU-funded, XML notice says no EU funds).

Risques

EU funding flag: structured data says EU-funded, XML notice says no EU funds. This may affect contract terms or eligibi...

Award criteria and detailed selection requirements are not provided in the notice.

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Admission to the Dynamic Purchasing System (SAD) is required.
  • Selection based on economic, financial, and professional capacity as per article 7.2 of the RC.
  • Candidates may be asked to update their application during the DPS validity.

Critères d'attribution

Lot 1

Not specified in provided data; award criteria will be defined in each specific contract under the DPS.

Acheteur

Localisation

LYON, FRA

Profil acheteur

Ouvrir le profil

Identifiant

130 002 223 00043

Activité

Health

Lots (1)

LOT-0001

Supply of Medicinal Products

Supply of medicinal products from identified therapeutic areas (annex 1) and equivalent medical devices to UniHA member establishments.

SuppliesDPSEU fundedElectronic submissionSME suitable

EUR 834.6M

Valeur estimée

Localisation

Lieu principal d'exécution : Le territoire national. Le lieu d'exécution sera précisé dans les marchés spécifiques, France

Durée

120 MONTH

Catégorie

Pharmaceutical products

Critères d'attribution

Not specified in provided data; award criteria will be defined in each specific contract under the DPS.

Date limite

Deadline Nov 24, 2031

Détails de la procédure

Date de publication
13 Apr 2026
Langues
French

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
252871-2026

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

France – Pharmaceutical products – 26-10 : ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2026

Aug 21

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9